Overview
Levofloxacin is a highly potent, broad-spectrum fluoroquinolone antibiotic. As the active L-isomer of ofloxacin, it exhibits significantly greater antibacterial activity than its predecessor. It is renowned for its excellent tissue penetration and high oral bioavailability, which allows for a seamless transition from intravenous to oral therapy. Levofloxacin is typically reserved for moderate to severe infections or those that have failed to respond to first-line agents. Key indications include community-acquired pneumonia, nosocomial pneumonia, acute bacterial exacerbations of chronic bronchitis, complicated urinary tract infections, acute pyelonephritis, and chronic bacterial prostatitis.

Mechanism of Action
Levofloxacin exerts a rapid bactericidal effect by targeting and inhibiting two essential bacterial enzymes: DNA gyrase (topoisomerase II) and topoisomerase IV. These enzymes are critical for the replication, transcription, repair, and recombination of bacterial DNA. By blocking their action, levofloxacin prevents the bacteria from unwinding and duplicating their DNA, leading to immediate cessation of cellular division and rapid bacterial cell death. Its broad spectrum covers many Gram-positive, Gram-negative, and atypical pathogens (like Legionella and Mycoplasma).

Dosage and Administration
The dosage and duration of therapy depend heavily on the type and severity of the infection. For adults, the standard oral or intravenous dose ranges from 250 mg to 750 mg administered once daily. A common regimen for community-acquired pneumonia is 500 mg once daily for 7 to 14 days, or a shorter, high-dose course of 750 mg once daily for 5 days. Oral tablets can be taken without regard to meals. However, it is crucial to administer levofloxacin at least 2 hours before or 2 hours after antacids containing magnesium or aluminum, as well as sucralfate, metal cations (iron), and multivitamin preparations with zinc, as these significantly reduce its absorption.

Side Effects and Risks
While effective, levofloxacin carries “black box warnings” for several severe and potentially irreversible adverse effects. These include an increased risk of tendinitis and tendon rupture (especially the Achilles tendon), peripheral neuropathy, and central nervous system effects (seizures, hallucinations, severe anxiety). It can also cause significant QT interval prolongation, leading to cardiac arrhythmias, and has been associated with exacerbating muscle weakness in patients with myasthenia gravis. Common, less severe side effects include nausea, diarrhea, and headache.

Contraindications
Levofloxacin is contraindicated in patients with a known hypersensitivity to levofloxacin or any other fluoroquinolone antibiotic. It should be avoided in patients with a history of myasthenia gravis due to the risk of exacerbating muscle weakness, which can lead to respiratory failure. Extreme caution is required in patients with a history of seizures, known QT prolongation, or those taking concurrent QT-prolonging medications. Dose adjustments are essential for patients with renal impairment.

Pregnancy and Lactation
The use of levofloxacin during pregnancy is generally not recommended. Animal studies have shown that fluoroquinolones can cause arthropathy (joint damage) in juvenile animals, raising concerns about potential cartilage damage in the developing human fetus. It should only be used if the potential benefit justifies the potential risk. Levofloxacin is excreted in human breast milk. Due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug.